Methyl 4-((2-(2-((2,3-dichlorophenyl)amino)-2-oxoacetyl)hydrazono)methyl)benzoate

Catalog No. :
ACMPAF602
CAS No. :
477732-11-9
Molecular Formula :
C17H13Cl2N3O4
Molecular Weight :
394.21

IUPAC Name:methyl (E)-4-((2-(2-((2,3-dichlorophenyl)amino)-2-oxoacetyl)hydrazineylidene)methyl)benzoate

Methyl 4-((2-(2-((2,3-dichlorophenyl)amino)-2-oxoacetyl)hydrazono)methyl)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-((2-(2-((2,3-dichlorophenyl)amino)-2-oxoacetyl)hydrazono)methyl)benzoate
IUPAC Namemethyl (E)-4-((2-(2-((2,3-dichlorophenyl)amino)-2-oxoacetyl)hydrazineylidene)methyl)benzoate
MDL No.MFCD00486475
Molecular FormulaC17H13Cl2N3O4
Molecular Weight394.21
SMILESO=C(OC)C1=CC=C(/C=N/NC(C(NC2=CC=CC(Cl)=C2Cl)=O)=O)C=C1
InChI KeyAYGCKXOJPINGOY-AWQFTUOYSA-N
SynonymSALOR-INT L238589-1EA;METHYL 4-(2-((2,3-DICHLOROANILINO)(OXO)ACETYL)CARBOHYDRAZONOYL)BENZOATE
CAS No.477732-11-9

Safety Data

Pictogram
Harmful or irritantHealth hazardEnvironmental hazard
Signal Word
Gefahr
Hazard Statement(s)
H302-H319-H372-H410
Precautionary Statement(s)
P260-P264-P273-P301+P312-P305+P351+P338-P314

Synthetic Route by SureRoute

1. ACMPAF602 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKMUJ259 route compound structure diagram
    ACKMUJ2591571-08-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMPAF602 route product structure diagram
    ACMPAF602477732-11-9
Inquiry

2. ACMPAF602 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDSAM359 route compound structure diagram
    ACDSAM359619-42-1 In Stock
  4. Then
  5. ACMPAF602 route product structure diagram
    ACMPAF602477732-11-9
Inquiry

Comments (0)